These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5510438)

  • 21. [On the variability of results of sensitivity determination in tuberculosis bacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):238-47. PubMed ID: 4973009
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new method of clinical evaluation of the results of drug resistance determination].
    Seri I
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 134(4):239-46. PubMed ID: 4297561
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the therapy of kidney tuberculosis].
    Wildbolz E
    Dtsch Med Wochenschr; 1966 Sep; 91(35):1561-2. PubMed ID: 5950542
    [No Abstract]   [Full Text] [Related]  

  • 24. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
    Erhard G
    Med Klin; 1969; 64(26):1215-7. PubMed ID: 4979959
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacteriological development in the triple combination antituberculosis treatment].
    Rodríguez A; Fernández E
    Rev Med Chil; 1966 Jul; 94(7):442-5. PubMed ID: 4169808
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modern chemotherapy of tuberculosis].
    Unholtz K
    Munch Med Wochenschr; 1970 May; 112(21):1003-11. PubMed ID: 5467739
    [No Abstract]   [Full Text] [Related]  

  • 28. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 29. [Survey over drug therapy of tuberculosis].
    Ovreberg K
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1090-3. PubMed ID: 1145595
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thiocarlide. Attempt of an evaluation].
    Protivinsky R
    Ther Ggw; 1969 Oct; 108(10):1410-1 passim. PubMed ID: 4908478
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP
    Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410
    [No Abstract]   [Full Text] [Related]  

  • 34. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary resistance against tuberculostatic agents in Indonesia].
    The Kie Seng ; Tan Thiam Hok ; Yang She Yen
    Med Klin; 1967 Oct; 62(42):1622-3. PubMed ID: 4969644
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study of therapeutic effect and side actions of 1314 TH and 1321 TH in the initial therapy of tuberculosis].
    Sunahara S; Nagasawa S
    Saishin Igaku; 1969 Apr; 24(4):922-7. PubMed ID: 5807960
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of cycloserine as an antituberculous drug.
    Gomi J
    Scand J Respir Dis Suppl; 1970; 71():130-2. PubMed ID: 5317742
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current views of urogenital tuberculosis].
    Fritjofsson A
    Lakartidningen; 1973 Apr; 70(14):1407-10. PubMed ID: 4697466
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness and problems of the treatment of tuberculosis under the environmental conditions of an underdeveloped country].
    Henneghien C; Ballez C; Horvath K; el-Fassi M
    Acta Tuberc Pneumol Belg; 1969; 60(6):821-32. PubMed ID: 5397018
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.